Design, Synthesis and Biological Assessment of Aryl-Isoxazole-Integrated Pyrimidin-2-yl Oxazolo[4,5-b]pyridine Derivatives as Anticancer Agents

A novel series of aryl-isoxazole-containing pyrimidin-2-yl oxazolo [4,5b]pyridine derivatives (11a-j) was designed and synthesized, and their structures were established using appropriate analytical and spectroscopic techniques.The newly synthesized compounds were subsequently subjected to preliminary in vitro anticancer evaluation against four human cancer cell lines, namely breast cancer (MCF-7), lung cancer (A549), colon cancer (Colo-205), and ovarian cancer (A2780), using the MTT assay.The synthesized compounds exhibited moderate to good cytotoxic effects when compared with etoposide, which was employed as the reference drug.Among the synthesized derivatives, compounds 11a, 11b, 11h, 11i, and 11j showed higher activity than the reference compound.Notably, derivative 11h demonstrated the most pronounced anticancer activity within the synthesized series.

Authors

Publication Details

Journal
International Journal of Scientific Research in Science and Technology
Published
2026-11-20
DOI
https://doi.org/10.32628/ijsrst13132614
Primary Topic
Heterocyclic Compound Synthesis and Bioactivity
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Design, Synthesis and Biological Assessment of Aryl-Isoxazole-Integrated Pyrimidin-2-yl Oxazolo[4,5-b]pyridine Derivatives as Anticancer Agents

N. Saritha, Khasim Saheb Shaik
International Journal of Scientific Research in Science and Technology
Heterocyclic Compound Synthesis and Bioactivity
article

Design, Synthesis and Biological Assessment of Aryl-Isoxazole-Integrated Pyrimidin-2-yl Oxazolo[4,5-b]pyridine Derivatives as Anticancer Agents

N. Saritha, Khasim Saheb Shaik
article en

Abstract

A novel series of aryl-isoxazole-containing pyrimidin-2-yl oxazolo [4,5b]pyridine derivatives (11a-j) was designed and synthesized, and their structures were established using appropriate analytical and spectroscopic techniques.The newly synthesized compounds were subsequently subjected to preliminary in vitro anticancer evaluation against four human cancer cell lines, namely breast cancer (MCF-7), lung cancer (A549), colon cancer (Colo-205), and ovarian cancer (A2780), using the MTT assay.The synthesized compounds exhibited moderate to good cytotoxic effects when compared with etoposide, which was employed as the reference drug.Among the synthesized derivatives, compounds 11a, 11b, 11h, 11i, and 11j showed higher activity than the reference compound.Notably, derivative 11h demonstrated the most pronounced anticancer activity within the synthesized series.

International Journal of Scientific Research in Science and TechnologyVol. 13(13)
Good health and well-being
Heterocyclic Compound Synthesis and Bioactivity
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon